Choom™ (CSE: CHOO; OTCQB: CHOOF) today announced the appointment of Chris Gagan as Senior Vice President of Marketing to lead its brand strategy and execution.
Earth Science is making waves in the hemp-derived cannabinoid (CBD), nutraceutical, pharmaceutical and medical device markets.
Legalizing marijuana nationwide would create at least $132 billion in tax revenue and more than a million new jobs across the United States in the next decade, according to a new study.
The turning tide in public sentiment and the advancement of legalization, both in Canada and throughout the world, are gradually destigmatizing marijuana use and giving rise to new cannabis subcultures and brands.
On September 13, 2017, Cannevert Therapeutics Ltd. (“CTL”), the research arm of Veritas Pharma Inc. (CSE: VRT) (OTC: VRTHF) (FRT: 2VP), filed a provisional patent for the use of a specific strain of cannabis to enhance the actions of opioid analgesics.
Marijuana Company of America, Inc. (OTC: MCOA), via its wholly-owned subsidiary hempSMART, is well positioned to take advantage of this industry growth through the development and marketing of innovative hemp-derived, CBD-based nutritional and wellness products.
Amidst increasing awareness regarding cannabinoids and their potential health benefits, Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP) is at the forefront of the booming cannabis industry with its patented delivery technology, DehydraTECH™.
Merger and acquisition (M&A) activity in the cannabis industry is heating up, and market analysts point to several important factors contributing to increased activity.